ARCHIVES

Was Dr. Bunn Insensitive Or Just Efficient? FDA Imbroglio Points To Larger Problems

This article is from The Cancer Letter archive.

Vol. 21 No. 43 | November 10, 1995

Download PDF Visit The Full Archive

Related Articles

NCI To Fund 22 Of 38 Clinical Investigator Applications, Five Of Them To Surgeons

June 1, 1984

Final Issues Of 1982

December 10, 1982

Trading In Stock Of U.S. Bioscience Halted, Newsletter Report Cited

October 9, 1992

NCI Bypass Budget For FY 1992 Requests $2.6 Billion Support grows In Congress

May 18, 1990

Racial Disparities Remain In Breast Cancer Care

October 29, 2010

VEGF-Trap Shows Activity Against Ovarian Cancer

July 27, 2007